Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Participants lived in regions between latitude 52.8 °N and latitude 51.4 °N, with 280 living in urban and 44 in rural settings.Clinical/demographic characteristics and differences in mean vitamin D by season of sampling, age categories, ethnicity & diagnosesTotal (n = 324)Male (n = 193)Female (n = 131)Mean age (SD)43.8 (10.1)43.2 (10.1)44.7 (10.2)Mean Duration of illness (SD)16.5 (10.4)17.1 (10.5)15.6 (10.4)Mean Vitamin D levels12.4 (7.3)12.2 (7.0)12.6 (7.8)Mean 25-OHD levels (ng/ml) ± SDTdf P ValueAge categoriesAge ≤ 44 (n = 172)Age > 44 (n = 152)12.1 ± 7.112.7 ± 7.5−0.7243220.663DiagnosisNon affective psychosis (i.e.

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Multiple reported designs.

Multiple reported designs

More than one design is explicitly reported; examine the supporting methods.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

This is a cross-sectional study of a random sample of people with established psychosis, recruited at baseline to the NIHR funded Improving Physical health and reducing substance use in Psychosis (IMPaCT) randomised controlled trial (RCT) [].

Source: Methods.

Potential participants were identified through their community mental health team care-coordinator.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Clinical correlates of vitamin D deficiency in established psychosis

Multiple reported designs · BMC Psychiatry · 2016

Original publication title

Clinical correlates of vitamin D deficiency in established psychosis

J. Lally; P. Gardner-Sood; M. Firdosi; C. Iyegbe; B. Stubbs; K. Greenwood; R. Murray; S. Smith; O. Howes; F. Gaughran

© Lally et al. 2016

Original publication · Publisher record · CC BY 4.0 · CC0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

This is the largest cross sectional study of serum 25-OHD levels in community dwelling individuals with established psychosis, indicating a high level of vitamin D deficiency. Lower vitamin D levels are associated with increased cardiovascular disease risk factors and in particular metabolic syndrome. Further research is needed to define appropriate protocols for vitamin D testing and supplementation in practice to see if this can improve cardiovascular disease risk.

An extract from the source publication. Read it in context.

At a glance

Abstract: What background does the paper provide?

Suboptimal vitamin D levels have been identified in populations with psychotic disorders.

We sought to explore the relationship between vitamin D deficiency, clinical characteristics and cardiovascular disease risk factors among people with established psychosis.

Source: Background Source: Background

Abstract: What methods does the paper describe?

Vitamin D levels were measured in 324 community dwelling individuals in England with established psychotic disorders, along with measures of mental health, cardiovascular risk and lifestyle choices. Vitamin D deficiency was defined as serum 25-hydroxyvitamin D (25-OHD) levels below 10 ng/ml (equivalent to <25 nmol/L) and “sufficient” Vitamin D as above 30 ng/ml (>50 nmol/L).

Source: Methods

Abstract: Results

The mean 25-OHD serum level was 12.4 (SD 7.3) ng/ml, (range 4.0-51.7 ng/ml). Forty nine percent (n = 158) were vitamin D deficient, with only 14 % (n = 45) meeting criteria for sufficiency. Accounting for age, gender, ethnicity and season of sampling, serum 25-OHD levels were negatively correlated with waist circumference (r = −0.220, p < 0.002), triglycerides (r = −0.160, p = 0.024), total cholesterol (r = −0.144, p = 0.043), fasting glucose (r = −0.191, p = 0.007), HbA1c (r = −0.183, p = 0.01), and serum CRP levels (r = −0.211, p = 0.003) and were linked to the presence of metabolic syndrome.

Source: Results

Abstract: Conclusions

This is the largest cross sectional study of serum 25-OHD levels in community dwelling individuals with established psychosis, indicating a high level of vitamin D deficiency. Lower vitamin D levels are associated with increased cardiovascular disease risk factors and in particular metabolic syndrome. Further research is needed to define appropriate protocols for vitamin D testing and supplementation in practice to see if this can improve cardiovascular disease risk.

Source: Conclusions
Authors’ abstract

Background

Suboptimal vitamin D levels have been identified in populations with psychotic disorders.

We sought to explore the relationship between vitamin D deficiency, clinical characteristics and cardiovascular disease risk factors among people with established psychosis.

Methods

Vitamin D levels were measured in 324 community dwelling individuals in England with established psychotic disorders, along with measures of mental health, cardiovascular risk and lifestyle choices. Vitamin D deficiency was defined as serum 25-hydroxyvitamin D (25-OHD) levels below 10 ng/ml (equivalent to <25 nmol/L) and “sufficient” Vitamin D as above 30 ng/ml (>50 nmol/L).

Results

The mean 25-OHD serum level was 12.4 (SD 7.3) ng/ml, (range 4.0-51.7 ng/ml). Forty nine percent (n = 158) were vitamin D deficient, with only 14 % (n = 45) meeting criteria for sufficiency. Accounting for age, gender, ethnicity and season of sampling, serum 25-OHD levels were negatively correlated with waist circumference (r = −0.220, p < 0.002), triglycerides (r = −0.160, p = 0.024), total cholesterol (r = −0.144, p = 0.043), fasting glucose (r = −0.191, p = 0.007), HbA1c (r = −0.183, p = 0.01), and serum CRP levels (r = −0.211, p = 0.003) and were linked to the presence of metabolic syndrome.

Conclusions

This is the largest cross sectional study of serum 25-OHD levels in community dwelling individuals with established psychosis, indicating a high level of vitamin D deficiency. Lower vitamin D levels are associated with increased cardiovascular disease risk factors and in particular metabolic syndrome. Further research is needed to define appropriate protocols for vitamin D testing and supplementation in practice to see if this can improve cardiovascular disease risk.

Trial registration

ISRCTN number is ISRCTN58667926 Date of registration: 23/04/2010

Publication and source details

Original title: Clinical correlates of vitamin D deficiency in established psychosis

J. Lally; P. Gardner-Sood; M. Firdosi; C. Iyegbe; B. Stubbs; K. Greenwood; R. Murray; S. Smith; O. Howes; F. Gaughran

BMC Psychiatry · 2016

© Lally et al. 2016https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.http://dx.doi.org/10.13039/501100000272National Institute for Health Research (GB)RP-PG-0606-1049Medical Research Council (UK)MC-A656-5QD30

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T14:47:14.161398+00:00

DOI: 10.1186/s12888-016-0780-2 · PMC4802895